Sponsor
Triangle Pharmaceuticals
Clinical research sponsor
Clinical trials
11 shownA Comparison of Emtricitabine and Stavudine Used With Didanosine Plus Efavirenz in HIV-Infected Patients Who Have Not Taken Anti-HIV DrugsNCT00006208 · lead sponsor · 2000-08-01
UNKNOWNA Comparison of Emtricitabine and Abacavir Used in a Three-Drug Combination in HIV-Infected Patients Who Have Never Taken Anti-HIV DrugsNCT00002362 · lead sponsor · 1999-08-01
SUSPENDEDComparing FTC and Lamivudine in HIV-Infected Patients on a Stable Anti-HIV Drug CombinationNCT00002416 · lead sponsor
COMPLETEDA Study of MKC-442 in HIV-Positive PatientsNCT00002413 · lead sponsor
COMPLETEDA Randomized, Double-Blind Study of MKC-442 Combined With Viracept in Patients Who Are Epivir + Retrovir Experienced and Are Protease Inhibitor- and Non-Nucleoside Reverse Transcriptase Inhibitor-NaiveNCT00002215 · lead sponsor
COMPLETEDEmtricitabine Given Once A Day With Other Anti-HIV Drugs in Children With HIVNCT00017992 · lead sponsor
UNKNOWNA Study of MKC-442 in Combination With Other Anti-HIV DrugsNCT00002412 · lead sponsor
COMPLETEDOnce Daily Antiretroviral Therapy in HIV Infected Adults Treated With HAARTNCT00196612 · collaborator · 2001-04-01
COMPLETEDPilot Study on Once Daily FTC, ddI, Efavirenz Combination in Antiretroviral Naive HIV Infected AdultsNCT00196599 · collaborator · 1999-02-01
COMPLETEDThe Safety and Effectiveness of Didanosine Plus Stavudine Plus Delavirdine Mesylate Plus MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease InhibitorsNCT00002420 · collaborator
TERMINATEDThe Safety and Effectiveness of Didanosine Plus Stavudine Plus Nevirapine Combined With MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease InhibitorsNCT00002418 · collaborator
TERMINATEDSponsor roles
lead sponsor7
collaborator4
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.